Alkali burn treated with 2% rebamipide ophthalmic suspension: a case report

Case Reports in Ophthalmology
Hidenori Sasaki, Takamichi Kokubun

Abstract

A 47-year-old man presented at the Ophthalmology Department of Saku City Asama General Hospital complaining of hyperemia and pain after industrial sodium hydroxide (approx. 40% concentration) had entered his left eye. With an epithelial defect of the bulbar and palpebral conjunctiva, ischemia of the inferior third of the limbal conjunctiva, a total corneal epithelial defect and mild corneal stromal opacity, the damage was determined as Roper-Hall grade III. 2% rebamipide ophthalmic suspension, which is used for dry eye disease, was administered 4 times a day followed by conventional treatment for serious alkali injury. The corneal epithelial defect was resolved, and there were no side effects. The effectiveness of 2% rebamipide ophthalmic suspension in both the repair and improvement of the damage in the conjunctival and corneal epithelia, and its anti-inflammatory effect suggest that it may be an effective treatment not only for dry eye disease but also for alkali ocular damage.

Citations

Jan 24, 2021·Journal of Oral Biosciences·Masae FurukawaKenji Matsushita

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Related Papers

American Journal of Ophthalmology
Shigeru KinoshitaRebamipide Ophthalmic Suspension Long-term Study Group
Clinical Ophthalmology
Hirotaka ItakuraShoji Kishi
Ophthalmology
Martina C HerwigHans E Grossniklaus
Bulletin de la Société belge d'ophtalmologie
J FRANCOISL EVENS
Bollettino di oculistica
J FRANCOISL EVENS
© 2021 Meta ULC. All rights reserved